These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1778331)

  • 41. [Time for booster doses against whooping cough for 10-year-old children].
    Carlsson RM; Ekholm L; Gothefors L; Granström M; Trolin I; Tegnell A
    Lakartidningen; 2005 Aug 29-Sep 4; 102(35):2394-8. PubMed ID: 16184889
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ACIP issues statement on acellular pertussis vaccine.
    Am Fam Physician; 1992 Jul; 46(1):286, 291. PubMed ID: 1621635
    [No Abstract]   [Full Text] [Related]  

  • 43. Acellular and whole-cell pertussis vaccines in Japan. Report of a visit by US scientists.
    Noble GR; Bernier RH; Esber EC; Hardegree MC; Hinman AR; Klein D; Saah AJ
    JAMA; 1987 Mar; 257(10):1351-6. PubMed ID: 3820444
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Using the Australian Childhood Immunisation Register to track the transition from whole-cell to acellular pertussis vaccines.
    Torvaldsen S; Hull BP; McIntyre PB
    Commun Dis Intell Q Rep; 2002; 26(4):581-3. PubMed ID: 12549528
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Benefits and risks of immunization against pertussis.
    Stuart-Harris C
    Dev Biol Stand; 1979; 43():75-83. PubMed ID: 520687
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolic and hematologic effects and immune complex formation related to pertussis immunization.
    Mink CM; Uhari M; Blumberg DA; Knip M; Lewis K; Christenson PD; Toyoda M; Jordan SC; Levin SR; Cherry JD
    Pediatr Res; 1990 Apr; 27(4 Pt 1):353-7. PubMed ID: 2188202
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of a two-component acellular pertussis vaccine in infants.
    Liese JG; Meschievitz CK; Harzer E; Froeschle J; Hosbach P; Hoppe JE; Porter F; Stojanov S; Niinivaara K; Walker AM; Belohradsky BH
    Pediatr Infect Dis J; 1997 Nov; 16(11):1038-44. PubMed ID: 9384336
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Introduction to the International Symposium on Pertussis Evaluation and Research on Acellular Pertussis Vaccines.
    Oya A
    Dev Biol Stand; 1991; 73():3-4. PubMed ID: 1778323
    [No Abstract]   [Full Text] [Related]  

  • 49. Safety follow-up in a cohort of Biken acellular DPT vaccine recipients in Japan.
    Chazono M; Hirota T; Yoshida I; Konobe T; Takaku K; Fukai K
    Dev Biol Stand; 1991; 73():323-7. PubMed ID: 1778326
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness of acellular pertussis vaccine in a routine immunization program: a multicenter, case-control study in Japan.
    Ohfuji S; Okada K; Nakano T; Ito H; Hara M; Kuroki H; Hirota Y
    Vaccine; 2015 Feb; 33(8):1027-32. PubMed ID: 25596459
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Whooping cough and pertussis vaccine: a comparison of risks and benefits in Britain during the period 1968-83.
    Stewart GT
    Dev Biol Stand; 1985; 61():395-405. PubMed ID: 3835080
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Efficacy of acellular pertussis vaccine].
    Saito T; Akamatsu T; Aoyama T; Iwai H; Gonda T; Murase Y; Yamshita N; Iwata T
    Kansenshogaku Zasshi; 1990 May; 64(5):564-9. PubMed ID: 2212750
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of whole-cell pertussis vaccine in preschool children in the United States.
    Onorato IM; Wassilak SG; Meade B
    JAMA; 1992 May; 267(20):2745-9. PubMed ID: 1578592
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protection against pertussis by acellular pertussis vaccines (Takeda, Japan): household contact studies in Kawasaki City, Japan.
    Kato T; Goshima T; Nakajima N; Kaku H; Arimoto Y; Hayashi F
    Acta Paediatr Jpn; 1989 Dec; 31(6):698-701. PubMed ID: 2516396
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Update on pertussis and diphtheria-tetanus toxoids-pertussis vaccination new strategies for clinicians. Introduction.
    Cherry JD
    Pediatr Infect Dis J; 1997 Apr; 16(4 Suppl):S76-7. PubMed ID: 9109160
    [No Abstract]   [Full Text] [Related]  

  • 56. [Epidemiology of pertussis and studies on culture positive pertussis cases in Japan].
    Kimura M; Kuno-Sakai H; Kunita N; Isomura S; Funahashi M; Sato Y
    Kansenshogaku Zasshi; 1996 Jan; 70(1):19-28. PubMed ID: 8822050
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Revisiting the possibility of serious adverse events from the whole cell pertussis vaccine: were metabolically vulnerable children at risk?
    Wilson K; Potter B; Manuel D; Keelan J; Chakraborty P
    Med Hypotheses; 2010 Jan; 74(1):150-4. PubMed ID: 19660877
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current epidemiology of pertussis in Japan.
    Kimura M; Kuno-Sakai H
    Pediatr Infect Dis J; 1990 Oct; 9(10):705-9. PubMed ID: 2235143
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Protection against pertussis by Japanese T type acellular pertussis vaccine: household contact study in Kawasaki City].
    Kato T; Matsuyoshi S; Goshima T; Nakajima N; Yamamoto H; Arimoto Y; Kaku H; Hayashi F
    Kansenshogaku Zasshi; 1989 Sep; 63(9):986-90. PubMed ID: 2509597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pertussis vaccines--1993.
    Schmitt HJ; Wagner S
    Eur J Pediatr; 1993 Jun; 152(6):462-6. PubMed ID: 8335011
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.